Paul Tudor Jones is no stranger to spotting macro turning points. But his firm, Tudor Investment‘s newest bet on International Business Machines Corp. IBM is suddenly facing a test few investors saw ...
Steve Cohen’s Point72 Buys $20M Of Surging Biotech Stock That Recently Priced $125M Offering To Advance Myeloma Treatment (International Business Times) Bill Ackman Calls Trump The ‘Most Pro-Business ...
You may be concerned about the recent declines in AI stocks such as NVDA. However, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing ...